Prognostic scores in primary biliary cholangitis patients with advanced disease

doi:10.4240/wjgs.v15.i8.1774

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3215)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

WORD

HTML

1605

Figures (1-2)

199

Tables (1-3)

225

Sum=2130

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

218

Download

742

Sum=960

Aug 27, 2023 (publication date) through Feb 3, 2025

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastrointest Surg. Aug 27, 2023; 15(8): 1774-1783
Published online Aug 27, 2023. doi: 10.4240/wjgs.v15.i8.1774

Table 2 Discriminative performance of the various risk prediction scores calculated at baseline and after 1 year of ursodeoxycholic acid therapy

C-statistic at various follow-up time points (95%CI)
Risk prediction model	Baseline	1 yr of UDCA
GLOBE		0.731 (0.681-0.782)
UK-PBC		0.727 (0.678-0.776)
APRI	0.592 (0.536-0.647)	0.347 (0.296-0.398)
FIB4	0.648 (0.593-0.704)	0.680 (0.628-0.732)
ALBI	0.705 (0.656-0.755)	0.725 (0.672-0.778)
Mayo	0.702 (0.653-0.751)	0.740 (0.690-0.791)

ALBI: Albumin-bilirubin; APRI: Aspartate aminotransferase-to-platelet ratio index; C-statistic: Concordance statistic; CI: Confidence interval; FIB4: Fibrosis-4 index; UDCA: Ursodeoxycholic acid.

Citation: Feng J, Xu JM, Fu HY, Xie N, Bao WM, Tang YM. Prognostic scores in primary biliary cholangitis patients with advanced disease. World J Gastrointest Surg 2023; 15(8): 1774-1783
URL: https://www.wjgnet.com/1948-9366/full/v15/i8/1774.htm
DOI: https://dx.doi.org/10.4240/wjgs.v15.i8.1774